Human Chorionic Gonadotropin (hCG) Market Exhaustive Analysis with USD $1,239 Million, Highest CAGR till 2025
The ever-increasing incidence of medical conditions associated with infertility faced by both males & females is set to propel the demand for hCG over the years
Human Chorionic Gonadotropin (hCG) Market by Technology (Natural Source Extraction, & Recombinant Technology), Therapeutic Area (Female Infertility Treatment,Male Hypogonadism, Oligospermic Treatment)”
NE WIN SIVERS DRIVE, PROVINCE: - PORTLAND, UNITED STATES, November 22, 2021 /EINPresswire.com/ -- Allied Market Research published a report, titled, Human Chorionic Gonadotropin (hCG) Market by Technology (Natural Source Extraction and Recombinant Technology), Therapeutic Area (Female Infertility Treatment, Male Hypogonadism, Oligospermic Treatment, and Others), and End User (Fertility Clinics, Research Institutes, and Others): Global Opportunity Analysis and Industry Forecast, 2017-2025. The report offers detailed insights on the top investment pockets, market size & share, driving forces & opportunities, strategic developments, and competitive landscape. According to the report, the global human chorionic gonadotropin (hCG) market garnered $688 million in 2017 and is expected to reach $1,239 million by 2025, growing at a CAGR of 7.6% from 2018 to 2025.— Allied Market Research
๐๐ฒ๐ ๐ฃ๐๐ ๐๐ฟ๐ผ๐ฐ๐ต๐๐ฟ๐ฒ ๐ข๐ณ ๐ง๐ต๐ถ๐ ๐ฅ๐ฒ๐ฝ๐ผ๐ฟ๐ ๐ช๐ถ๐๐ต ๐๐ฒ๐๐ฎ๐ถ๐น๐ฒ๐ฑ ๐๐ป๐ฎ๐น๐๐๐ถ๐ ๐ https://www.alliedmarketresearch.com/request-sample/3418
Surge in adoption of hCG in pain management & weight loss and increase in incidence of infertility-related issues drive the growth of the market. However, warnings and cautions issued by the USFDA regarding the side-effects of hCG therapy would restrain the market growth. Conversely, the implementation of recombinant technology would create new pathways for the market players in future.
๐๐ผ๐บ๐ฝ๐ฟ๐ฒ๐ต๐ฒ๐ป๐๐ถ๐๐ฒ ๐ฐ๐ผ๐บ๐ฝ๐ฒ๐๐ถ๐๐ถ๐๐ฒ ๐ฎ๐ป๐ฎ๐น๐๐๐ถ๐ ๐ฎ๐ป๐ฑ ๐ฝ๐ฟ๐ผ๐ณ๐ถ๐น๐ฒ๐ ๐ผ๐ณ ๐บ๐ฎ๐ท๐ผ๐ฟ ๐บ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐ฝ๐น๐ฎ๐๐ฒ๐ฟ๐, ๐๐๐ฐ๐ต ๐ฎ๐
Bristol Myers Squibb Company, Merck & Co., Inc., Ferring B.V., Fresenius Kabi AG, Cigna, Sun Pharmaceutical Industries Ltd, Lee BioSolutions Inc., Sanzyme, Scripps Laboratories, and Lupin AB.
The other players operating in the global human chorionic gonadotropin (hCG) market include Kamiya Biomedical Company, Intas Pharmaceuticals, Prospec-Tany Technogene Ltd., Cipla Limited, Biocare Medical, LLC, MyBioSource, Zydus Cadila, and Life Medicare & Biotech Pvt. Ltd.
๐ท ๐๐จ๐ฏ๐ข๐-๐๐ ๐๐๐๐ง๐๐ซ๐ข๐จ:
1) The Covid-19 pandemic and followed by lockdown has affected several manufacturing industries.
2) The prolonged lockdown resulted in a disrupted supply chain and increased the prices of raw materials.
3) However, as the world has been recovering from the pandemic, the market is estimated to get back on track.
Female infertility treatment segment to remain dominant by 2025
The female infertility treatment segment accounted for nearly half of the total market share in 2017. This segment is expected to maintain its dominance by 2025, owing to increase in infertility-related issues such as polycystic ovary syndrome (PCOS).
Get Detailed COVID-19 Impact Analysis on the Human Chorionic Gonadotropin (hCG) Market @ https://www.alliedmarketresearch.com/request-for-customization/3418?reqfor=covid
๐๐ฒ๐ ๐๐ฒ๐ป๐ฒ๐ณ๐ถ๐๐ ๐ณ๐ผ๐ฟ ๐ฆ๐๐ฎ๐ธ๐ฒ๐ต๐ผ๐น๐ฑ๐ฒ๐ฟ๐
โฆThe study provides an in-depth analysis of the Human Chorionic Gonadotropin (hCG) Market along with the current trends and future estimations to elucidate the imminent investment pockets.
โฆIt offers Human Chorionic Gonadotropin (hCG) Market analysis from 2018 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
โฆA comprehensive analysis of four regions is provided to determine the prevailing opportunities.
โฆThe profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global Human Chorionic Gonadotropin (hCG) Market growth.
๐ง๐ฎ๐ฏ๐น๐ฒ ๐ผ๐ณ ๐๐ผ๐ป๐๐ฒ๐ป๐ ๐
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market Definition and Scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies, 2017
3.3. Top player positioning, 2017
3.4. Porterโs five forces analysis
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Technological advancements in laboratory equipment
3.5.1.2. Rise in private and public healthcare investments
3.5.1.3. Favorable insurance policies related to laboratory equipment
3.5.1.4. Surge in research related to life science and biotechnology
๐๐ป๐พ๐๐ถ๐ฟ๐ฒ ๐๐ฒ๐ณ๐ผ๐ฟ๐ฒ ๐๐๐๐ถ๐ป๐ด ๐๐ฒ๐ฟ๐ฒ @ https://www.alliedmarketresearch.com/purchase-enquiry/3418
๐๐ฟ๐ฒ๐พ๐๐ฒ๐ป๐๐น๐ ๐๐๐ธ๐ฒ๐ฑ ๐ค๐๐ฒ๐๐๐ถ๐ผ๐ป๐?
Q1. What is the total market value of artificial intelligence for Human Chorionic Gonadotropin (hCG) Market reports?
Q2. What would be forecast period in the market report?
Q3. Which is base year calculated in the artificial intelligence for Human Chorionic Gonadotropin (hCG) Market report?
Q4. Which are the top companies hold the market share in artificial intelligence for Human Chorionic Gonadotropin (hCG) Market?
๐๐๐ฒ๐ป๐๐ฒ ๐๐ฎ๐๐ถ๐ฐ ๐ฃ๐น๐ฎ๐ป | ๐๐ถ๐ฏ๐ฟ๐ฎ๐ฟ๐ ๐๐ฐ๐ฐ๐ฒ๐๐ | ๐ญ ๐ฌ๐ฒ๐ฎ๐ฟ ๐ฆ๐๐ฏ๐๐ฐ๐ฟ๐ถ๐ฝ๐๐ถ๐ผ๐ป |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter
โWe have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.โ
๐ง๐ฟ๐ฒ๐ป๐ฑ๐ถ๐ป๐ด ๐ฅ๐ฒ๐ฝ๐ผ๐ฟ๐๐ ๐ถ๐ป ๐๐ฒ๐ฎ๐น๐๐ต๐ฐ๐ฎ๐ฟ๐ฒ ๐๐ป๐ฑ๐๐๐๐ฟ๐ (๐๐ผ๐ผ๐ธ ๐ก๐ผ๐ ๐๐ถ๐๐ต ๐ญ๐ฌ% ๐๐ถ๐๐ฐ๐ผ๐๐ป๐):
Intraocular Lens Market โ Opportunity & Industry Forecast, 2022
Nurse Call Systems Market โ Opportunity & Industry Forecast, 2023
๐๐ฏ๐ผ๐๐ ๐จ๐
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
David Correa
Allied Analytics LLP
+1 503-894-6022
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn